Michael A. Klobuchar
Insider Reports History
- Location
- Kenilworth, NJ
- Signature
- /s/ Benjamin Thorner, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Michael A. Klobuchar:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Merck & Co., Inc. | EVP - Chief Strategy Officer | Common Stock | 23,621 | $3,011,939 | $127.51 | 04 May 2024 | Direct |
| REVVITY, INC. | Director | Common Stock | 5,088 | $473,285 | $93.02 | 30 Apr 2025 | Direct |
| Merck & Co., Inc. | EVP - Chief Strategy Officer | Common Stock | 6 | $802 | $127.51 | 04 May 2024 | By Child |
| Merck & Co., Inc. | EVP - Chief Strategy Officer | Restricted Stock Unit | 0 | $0 | $127.51 | 04 May 2024 | Direct |
| Eikon Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 87,157 | 02 Mar 2026 | Direct | ||
| Merck & Co., Inc. | EVP - Chief Strategy Officer | Stock Option (Right to Buy) | 20,508 | 30 Apr 2024 | Direct | ||
| Merck & Co., Inc. | EVP - Chief Strategy Officer | Common Stock - 401(k) Plan | 867 | 04 May 2024 | By 401(k) | ||
| Merck & Co., Inc. | EVP - Chief Strategy Officer | Common Stock - 401(k) Plan | 697 | 04 May 2024 | By Spouse |
Insider Reports Filed by Michael A. Klobuchar
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| EIKN | Eikon Therapeutics, Inc. | 02 Mar 2026 | 1 | $0 | 4 | Chief Operating Officer | 04 Mar 2026, 17:04 |
| EIKN | Eikon Therapeutics, Inc. | 04 Feb 2026 | 0 | $0 | 3 | Chief Operating Officer | 04 Feb 2026, 21:19 |
| RVTY | REVVITY, INC. | 30 Apr 2025 | 2 | $0 | 4 | Director | 01 May 2025, 16:05 |
| MRK | Merck & Co., Inc. | 04 May 2024 | 3 | +$57,380 | 4 | EVP - Chief Strategy Officer | 06 May 2024, 16:06 |
| RVTY | REVVITY, INC. | 01 May 2024 | 2 | $0 | 4 | Director | 02 May 2024, 16:05 |
| MRK | Merck & Co., Inc. | 30 Apr 2024 | 1 | $0 | 4 | EVP - Chief Strategy Officer | 02 May 2024, 16:09 |
| RVTY | REVVITY, INC. | 15 Feb 2024 | 2 | $0 | 4 | Director | 16 Feb 2024, 16:05 |
| RVTY | REVVITY, INC. | 01 Feb 2024 | 0 | $0 | 3 | Director | 01 Feb 2024, 16:05 |
| MRK | Merck & Co., Inc. | 22 Jan 2024 | 1 | +$465,299 | 4 | EVP - Chief Strategy Officer | 24 Jan 2024, 16:01 |
| MRK | Merck & Co., Inc. | 04 May 2023 | 3 | +$53,081 | 4 | EVP - Chief Strategy Officer | 05 May 2023, 17:06 |
| MRK | Merck & Co., Inc. | 02 May 2023 | 1 | $0 | 4 | EVP - Chief Strategy Officer | 04 May 2023, 18:26 |
| MRK | Merck & Co., Inc. | 01 May 2023 | 3 | +$50,691 | 4 | EVP - Chief Strategy Officer | 03 May 2023, 15:00 |
| MRK | Merck & Co., Inc. | 23 Jan 2023 | 1 | +$291,292 | 4 | EVP - Chief Strategy Officer | 25 Jan 2023, 15:41 |
| MRK | Merck & Co., Inc. | 03 May 2022 | 4 | +$39,108 | 4 | EVP - Chief Strategy Officer | 05 May 2022, 17:07 |
| MRK | Merck & Co., Inc. | 03 May 2022 | 3 | +$34,359 | 4 | EVP - Chief Strategy Officer | 04 May 2022, 16:53 |
| MRK | Merck & Co., Inc. | 01 May 2022 | 3 | +$38,935 | 4 | EVP - Chief Strategy Officer | 03 May 2022, 16:13 |
| MRK | Merck & Co., Inc. | 24 Feb 2022 | 1 | +$220,089 | 4 | EVP - Chief Strategy Officer | 28 Feb 2022, 15:22 |
| MRK | Merck & Co., Inc. | 05 Jul 2021 | 0 | $0 | 3 | EVP - Chief Strategy Officer | 15 Jul 2021, 11:02 |